Israeli Prime Minister Benjamin Netanyahu announced that he was diagnosed with early-stage prostate cancer and underwent secret surgery and targeted treatment, disclosing the medical episode only after doctors confirmed the malignancy had "completely disappeared." The 76-year-old leader said he kept the diagnosis confidential so that "Tehran's terror regime would not be able to harness it as propaganda."
Netanyahu shared the news in a post on X, framing it in characteristically direct terms. He said he was healthy, in excellent physical condition, and that a "minor medical issue" with his prostate had been "completely treated."
The disclosure lands at a moment of extraordinary complexity for Israel. A ceasefire with Hezbollah was just extended, diplomatic meetings at the White House are on the horizon, and Israeli Defence Minister Israel Katz has publicly declared the IDF "prepared to resume the War in Iran." Against that backdrop, the prime minister's decision to conceal a cancer diagnosis, and reveal it only on his own terms, carries both personal and strategic weight.
An annual health report from the Prime Minister's Office, as reported by The US Sun, stated that Netanyahu underwent surgery on December 29, 2024, for benign prostatic hyperplasia. The procedure was completed without complications, and he was placed under observation.
Netanyahu himself described the surgery as having taken place "a year and a half ago," and said he had been under routine medical monitoring since. During a subsequent check-up, a follow-up MRI revealed a lesion on the prostate.
Prof. Aharon Popovzer, director of the Sharret Institute at Hadassah Hospital in Jerusalem, provided clinical detail. He said the mass measured 0.9 centimetres and was identified as prostatic adenocarcinoma, prostate cancer, at a very early stage. Popovzer said the finding came "a few months ago, as part of a routine check-up."
Netanyahu then underwent what he called "targeted treatment", described elsewhere as radiation therapy overseen by Popovzer. The prime minister said he "went to a few short treatments, read a book, and continued working." The spot, he said, "disappeared completely."
Separately, the report noted that Netanyahu had undergone a "modern, specialised kidney treatment" at Hadassah Medical Center roughly two and a half months earlier. No further details on that procedure were provided.
Netanyahu offered a blunt rationale for keeping the diagnosis under wraps. He said he wanted to prevent Iran from exploiting the information. That explanation tracks with a leader who has spent decades managing not only domestic politics but the perceptions of hostile foreign powers.
Whether one agrees with the decision to conceal a sitting head of state's cancer diagnosis, the reasoning is not difficult to follow. Israel operates in a region where perceived weakness invites provocation. Netanyahu clearly calculated that disclosing a malignancy, even a treatable one, would hand adversaries a talking point. Iran's Foreign Minister Abbas Araghchi had already been publicly blasting what he called the "failure of Israel's terrorist killings" during the war. The last thing Netanyahu wanted was to add fuel to that fire.
The broader diplomatic picture underscores the stakes. President Trump has been navigating multiple international confrontations, and he announced that the warring nations extended their ceasefire with Hezbollah by three weeks after the latest peace talks. Trump said a Thursday meeting between the Israeli and Lebanese ambassadors "went very well."
Netanyahu is due to meet Lebanese President Joseph Aoun at the White House in the coming weeks, a diplomatic engagement that demands a leader projecting strength, not one fielding questions about his health.
The prime minister's X post was detailed and personal, unusual for a leader who typically projects ironclad composure. He drew a direct parallel between his approach to national security threats and his approach to the cancer diagnosis:
"When I'm given information in time about a potential danger, I want to address it immediately. This is true on the national extensive and also on the personal comprehensive. That's what I did."
He thanked the medical teams at Hadassah Hospital and closed with a public-health appeal to Israeli citizens:
"From you, citizens of Israel, I have only one request: Take care of your health. Get checked, and follow the doctors' instructions."
That message, coming from a wartime prime minister who just beat cancer, will carry weight in Israel, where tensions over the broader Middle East conflict remain at a high pitch.
Netanyahu's diagnosis puts him in a large and growing cohort. Prostate cancer is the fourth most common cancer worldwide and the most common in men. One in eight men will receive the diagnosis in their lifetime. Globally, there are 1.4 million new cases every year, and nearly 400,000 deaths.
In the United Kingdom alone, roughly 55,000 new cases are diagnosed annually. The disease accounts for 28 percent of all new cancer cases in men there and 14 percent of cases in men and women combined. Since the early 1990s, UK cases have increased by 53 percent. The disease is most common in men aged 75 to 79, Netanyahu, at 76, falls squarely in that window.
The survival picture, however, has improved dramatically. Survival has tripled over the last 50 years in the UK, with more than 78 percent of patients now surviving 10 years or more. About 490,000 men are currently living with or after prostate cancer in the UK alone. Incidence rates are projected to rise 15 percent between 2023 and 2040, but mortality rates are expected to fall five percent over the same period.
Netanyahu's case, caught early, with no spread or metastases, sits at the most favorable end of the spectrum. The contrast with former President Joe Biden's situation is stark. Biden is currently receiving radiation therapy and hormone treatment for prostate cancer that was diagnosed after he left office. His cancer has spread to the bone and carries a Gleason score of 9, one of the most aggressive classifications. Biden aide Kelly Scully confirmed the treatment regimen publicly.
The two cases illustrate the vast range of outcomes prostate cancer can produce. Netanyahu's early detection and rapid treatment left, by his account, "no trace." Biden faces a far longer and more uncertain road.
The health disclosure arrives as Israel faces an unusually dense set of challenges. The ceasefire with Hezbollah, which was initially set for ten days, had been due to expire on Monday but has now been extended into May. Defence Minister Katz has said Israel is awaiting a "green light" from the United States to return Iran to "the Stone Age", language that reflects the intensity of the current moment.
Netanyahu's upcoming meeting with Lebanese President Aoun at the White House will test whether the ceasefire extension can hold and whether a more durable arrangement is possible. The White House itself has been the site of significant security developments, and the diplomatic calendar is crowded.
For Netanyahu, the cancer revelation is a calculated move. He chose the timing. He controlled the narrative. He presented himself as a man who identified a threat, acted decisively, and eliminated it, the same story he tells about national defense. Whether that framing holds depends on what comes next, both medically and politically.
Several details remain unclear. The exact date of the follow-up monitoring that revealed the lesion has not been specified. The descriptions of the lesion's size vary across Netanyahu's own statement, the health report, and Prof. Popovzer's account, "less than a centimeter," "less than one millimetre," and "0.9 centimetres," respectively, a discrepancy that has not been publicly reconciled. The precise nature of the "targeted treatment" and whether it differed from the radiation therapy Popovzer oversaw has also not been clarified.
None of these gaps necessarily signal anything troubling. But for a disclosure built around the theme of transparency, the inconsistencies are worth noting. Political leaders and the institutions around them have a long history of managing health information to suit the moment.
Netanyahu beat the cancer. The harder question is whether a wartime prime minister should have the unilateral power to decide when his country learns he had it.
